Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
935 items
Fundus photograph of age-related macular degeneration showing drusen.

NEI Releases Complete Data from Age-Related Eye Disease Study

The National Eye Institute (NEI), part of the National Institutes of Health (NIH), announces the release of more than 10 years of data collected during the Age-Related Eye Disease Study (AREDS).
Girl and physician conducting CI exam

More Effective Treatment Identified for Common Childhood Vision Disorder

Scientists have found a more effective treatment for a common childhood eye muscle coordination problem called convergence insufficiency (CI).
National Eye Institute logo.

Phase 1 Clinical Trial Results of Gene Transfer for Leber Congenital Amaurosis Reported

Three young adults with Leber Congenital Amaurosis-a severe degenerative disease of the retina caused by a mutation in the RPE65 gene-reported improvements in vision after undergoing a specialized gene transfer procedure.
National Eye Institute logo.

Older Treatment May Be More Effective in Preserving Sight for Some Patients with Diabetes

A promising new drug therapy used to treat abnormal swelling in the eye-a condition called diabetic macular edema-proved less effective than traditional laser treatments in a study funded by the National Eye Institute (NEI), part of the NIH.
National Eye Institute logo.

Update on Vitamin A as a Treatment for Retinitis Pigmentosa

Investigators reported in 1993 that the progressive course of retinal degeneration, as assessed by the electroretinogram (ERG), was slower on average among adults with retinitis pigmentosa.
National Eye Institute logo.

Gene Transfer for Leber Congenital Amaurosis

Two groups of investigators have reported independently on their initial observations from Phase I clinical trials of gene transfer for Leber congenital amaurosis (LCA) caused by mutations in the RPE65 gene.
National Eye Institute logo.

Older Corneas Suitable for Transplantation

The age pool of corneas for transplant should be expanded to include donors up to 75 years of age, based on findings from a study funded by the National Eye Institute (NEI), one of the National Institutes of Health.
National Eye Institute logo.

Survey Shows Americans Lack Critical Facts about Maintaining Eye Health

Most Americans do not know the risks and warning signs of diseases that could blind them if they don’t seek timely detection and treatment.
Two young boys smile at camera. A dark spot representing vision loss from AMD blocks the center of the image.

Comparison of AMD Treatments Trials (CATT): Lucentis - Avastin Trial

The National Eye Institute (NEI) of the National Institutes of Health (NIH) announces the start of a multicenter clinical trial to compare the relative safety and effectiveness of two drugs currently used to treat advanced age-related macular degeneration
National Eye Institute logo.

Statement on Clinical Trial of Gene Transfer Therapy for Childhood-Onset Blindness

The National Eye Institute (NEI) of the National Institutes of Health (NIH) is supporting a phase I clinical trial to assess the safety of gene transfer in treating people with a form of Leber congenital amaurosis (LCA).